487 results on '"Ram, C. Venkata S."'
Search Results
2. Achieving the Latest American Heart Association and American College of Cardiology Therapeutic Goals for Hypertension With Combination Therapy and Its Effects on Blood Pressure and Central Hemodynamic Parameters
3. Management of American Heart Association/American College of Cardiology-Defined Stage 2 Hypertension by Cardiologists in India
4. A New Class of Drugs Approved in the United States for Hypertension: Endothelin Antagonists.
5. The Latest Hypertension Guidelines At-a-Glance: No Need for a QR Code
6. Isolated diastolic hypertension and its risk factors in semi-rural population of South India
7. Risk factors predisposing to acute stroke in India: a prospective study
8. The latest hypertension guidelines: from encryption to decryption, finally!
9. Metabolic Syndrome in South Asians
10. Physician, heal thyself: Thou shalt not overlook hypokalemia in clinical practice
11. Resistant Hypertension in Patients with Chronic Kidney Disease
12. Physiological Rationale for Renal Denervation Therapy in Hypertension
13. Indian guidelines on hypertension-IV (2019): need to differentiate thiazide-like diuretics
14. Pharmacologic treatment of hypertension
15. Hypertension epidemiology in India: emerging aspects
16. Recent Guidelines for Hypertension: A Clarion Call for Blood Pressure Control in India
17. ‘Normal’ blood pressure is no longer a safe haven: take shelter under ‘optimal’ blood pressure
18. Prevalence and correlates of hypertension in a semi-rural population of Southern India
19. “Hypertension guidelines: Good-bye to confusion and welcome to clarity”
20. Status of Renal Denervation Therapy for Hypertension: Still in Search of the Magic Bullet
21. Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India
22. The collateral damage of COVID-19 to cardiovascular services: a meta-analysis
23. Renal denervation therapy for hypertension: all that glitters is not gold
24. Beta-Blockers in Hypertension
25. Metabolic Syndrome in South Asians
26. Resistant Hypertension in Patients with Chronic Kidney Disease
27. Physiological Rationale for Renal Denervation Therapy in Hypertension
28. Resistant Hypertension
29. Angiotensin Receptor Blockers: Current Status and Future Prospects
30. The Evolving Definition of Systemic Arterial Hypertension
31. Treatment of hypertensive urgencies and emergencies
32. Management of hypertension in hemodialysis patients
33. ONTARGET study of telmisartan, ramipril, or both in high-risk patients
34. Renal denervation therapy for hypertension: truths and half-truths
35. Normotensive aging: finally, an ‘iron in the fire’
36. collateral damage of COVID-19 to cardiovascular services: a meta-analysis.
37. Hypertension
38. Review of resistant hypertension
39. Concentric vs. Eccentric Left Ventricular Hypertrophy: Does It Matter? It Is All “Blood Pressure Centered”
40. Pharmacologic treatment of hypertension
41. Contributors
42. Refractory hypertension
43. Effects of an amlodipine- and olmesartan medoxomil-based titration regimen in patients with hypertension, type 2 diabetes and metabolic syndrome.: 21E.
44. Are angiotensin converting enzyme inhibitors and angiotensin receptor blockers becoming the treatment of choice in African-Americans?
45. Antihypertensive Drugs: An Overview
46. Fibromuscular dysplasia of the renal arteries
47. Role of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease
48. 2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidence
49. In memoriam: Dr Norman M. Kaplan (1931–2020)
50. The triad of orthostatic hypotension, blood pressure variability, and arterial stiffness: a new syndrome?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.